• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Tresiba Fail, Novo's Shit Does Stink

Quote




Anonymous said:
BAAAHAAHHAAH!!!
Click to expand...

I love it! Novo thinks rules don't apply to them. You don't own the FDA Novo creeps. Have fun selling old technology in 4 person pods and competing against generic Lantus. The Takeda alo/Actos combo will kick Victozas ass this summer too, not to mention GSK has a better GLB-1 coming out with CVOT data. CVOT data? What? Does Novo even know what that's is? BAWAHAHAHAHAHAHA!!!!
 




Anonymous said:
I love it! Novo thinks rules don't apply to them. You don't own the FDA Novo creeps. Have fun selling old technology in 4 person pods and competing against generic Lantus. The Takeda alo/Actos combo will kick Victozas ass this summer too, not to mention GSK has a better GLB-1 coming out with CVOT data. CVOT data? What? Does Novo even know what that's is? BAWAHAHAHAHAHAHA!!!!
Click to expand...

GLB1??? Your attempt at talking down someone is funnier then what you think you are, dumbass
 












Top Bottom
Back
Quote